Movano will demo its smart ring at CES 2022. The device is expected to be a more affortdable alternative to Oura ring, while monitoring much the same metrics. The hope is that eventually, it will even be able to monitor glucose and blood pressure.
There’s little competition in the smart ring space at the moment. But this is looking like it will change in 2022.
A number of companies are working on their own solutions. Apple is a name that has figured in this conversation for years now, but with little to show. Other companies have started to register smart ring patents, too.
Essential reading: Best fitness trackers and health gadgets
One of these is Fitbit. With Google’s money behind it, perhaps we might finally see a smart ring from the San Francisco wearables pioneer. Another is Oppo. Earlier this month the company registered a smart ring patent with the Chinese authorities.
We are not sure when/if we will see smart rings from these companies. Just because they have filed patents does not mean they will produce working devices. If nothing else, it does show is that they are thinking of exploring the smart ring space.
The Movano Ring, on the other hand, is something that is definitely under development. In fact, the device will be demoed at CES 2022 in Las Vegas. This will be the first such product from health tech company Movano.
Designed primarily for women, the sleek looking ring will be able to monitor a slew of health metrics. This includes activity, sleep, heart rate, heart rate variability (HRV), sleep, restoration, temperature, blood oxygen, steps and calories. That’s much the same list that the $300 Oura Ring currently monitors. The plan is for Movano Ring to be one of the “most affordable health devices”.
The accompanying smartphone app will spit out easy to understand actionable insights on the data the ring collects. The idea is to link the cause and effect of individual metrics. For example, you’ll be able to know how your exercise habits impact your sleep patterns, HRV and more. That way you’ll be able to take “a more proactive approach to mitigating the risks of chronic disease.”
Movano is currently working at obtaining FDA approval for its tech. While the first iteration of the ring is not expected to have FDA clearances, the goal is to ultimately get Class II designation as a medical device.
However, the company’s ambitions do not end there. The hope is that the ring will eventially be able to monitor glucose non-invasively and provide cuffless blood pressure information. Its proprietary radio frequency technology that is used to obtain this type of data is currently undergoing clinical trials. If this is proven successful, it will be a game-changer.
The Movano Ring will be showcased at CES 2022 in Las Vegas in early January. The first beta public release of the device is expected in the latter part of 2022.
Like this article? Subscribe to our monthly newsletter and never miss out!